Lipoprotein-associated phosphoplipase a2 (lp-pla2) as a therapeutic target to prevent retinal vasopermeability during diabetes

Paul Canning, Bridget-Ann Kenny, Vivien Prise, Josephine Glenn, Mosharraf Sarker, Natalie Hudson, Martin Brandt, Francisco J. Lopez, David Gale, Philip J. Luthert, Peter Adamson, Patric Turowski, Alan W. Stitt

    Research output: Contribution to journalArticlepeer-review

    138 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Lipoprotein-associated phosphoplipase a2 (lp-pla2) as a therapeutic target to prevent retinal vasopermeability during diabetes'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science